Alexion Pharmaceuticals I... (ALXN)
NASDAQ: ALXN
· Real-Time Price · USD
182.50
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Alexion Pharmaceuticals Revenue
Alexion Pharmaceuticals reported an annual revenue of $6.07B, reflecting a 21.61% growth. For the quarter ending March 31, 2021, Alexion Pharmaceuticals generated $1.64B in revenue.
Revenue (ttm)
6.07B
Revenue Growth
21.61%
Price / Sales Ratio
5.64
Revenue / Employee
1.58M
Employees
3,837
Market Cap
0
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2020 | 6.07B | +21.61% |
Dec 31, 2019 | 4.99B | +20.81% |
Dec 31, 2018 | 4.13B | +16.34% |
Dec 31, 2017 | 3.55B | +15.15% |
Dec 31, 2016 | 3.08B | +18.43% |
Dec 31, 2015 | 2.6B | +16.58% |
Dec 31, 2014 | 2.23B | +43.99% |
Dec 31, 2013 | 1.55B | +36.79% |
Dec 31, 2012 | 1.13B | +44.76% |
Dec 31, 2011 | 783.43M | +44.82% |
Dec 31, 2010 | 540.96M | +39.85% |
Dec 31, 2009 | 386.8M | +49.29% |
Dec 31, 2008 | 259.1M | +259.65% |
Dec 31, 2007 | 72.04M | +4523.94% |
Dec 31, 2006 | 1.56M | -66.20% |
Jul 31, 2004 | 4.61M | +425.54% |
Jul 31, 2003 | 877K | -86.58% |
Jul 31, 2002 | 6.54M | -44.63% |
Jul 31, 2001 | 11.8M | -44.94% |
Jul 31, 2000 | 21.44M | +14.05% |
Jul 31, 1999 | 18.8M | +276.00% |
Jul 31, 1998 | 5M | +31.58% |
Jul 31, 1997 | 3.8M | +46.15% |
Jul 31, 1996 | 2.6M | n/a |